Register for our free email digests:
Latest From DePuy Orthopaedics Inc.
2016 was a year of surprise and change in political circles, but that's nothing new for the medtech industry, which over a number of years has become accustomed to health care systems demanding different and ever-higher levels of service. Smart medtechs have been ahead of the curve, but the whole industry now factors in clients' wider needs in a holistic approach to patient care. Many companies' current M&A policies are already reflecting the changes to come.
The bellwether case resulted in a jury award of $1b to a group of six California patients who say they were injured by the metal-on-metal hip. J&J plans to appeal.
This is the first win for patients and the second case to go to trial of more than 7,000 complaints against DePuy Orthopedics filed nationwide alleging the metal-on-metal version of the Pinnacle artificial hip broke prematurely and required resurfacing.
A final order from FDA calls for manufacturers to submit PMAs or take their metal-on-metal hip devices off the market by May 18. The widely anticipated move is part of a broader response to elevated adverse event rates tied to the products.
- Therapeutic Areas
- Pacific Rim
- Parent & Subsidiaries
- Tosoh Corp.
- Senior Management
- Minoru Aoyama, Group General Mgr.
- Contact Info
Phone: (81) 35 869 141
1-11-39, Akasaka, Minato-ku
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.